UnitedHealth Group Incorporated Q4 FY2025 earnings call

• Driving greater operational disciplines, leveraging technology and AI, and renewing commitment to innovation, agility, and accountability.
• Repositioning assets not aligned with serving the U.S. health system.
• Strengthening management team with internal depth and external talent.
• UnitedHealthcare repriced insurance businesses for margin recovery; Optum new leaders driving operational improvements; alignment of OptumFinancial Services with OptumInsight.
• Focus on margin recovery through product repositioning and repricing, with steady efficiency gains via AI and improved customer experience.

UnitedHealthcare

• Medicare: 2025 medical cost trend was ~7.5%, supporting 2026 trend expectation of 10%. Anticipates Medicare Advantage membership contraction of 1.3 million to 1.4 million in 2026, with Medicare margins expected to improve by ~50 basis points from 2025.
• Medicaid: Expected incremental pressure in 2026 due to state funding shortfalls, with membership contraction of approximately 565,000 to 715,000.
• Commercial: Took steps in commercial pricing and cost management, re-priced individual ACA market nearly all states, with group self-funded offerings showing momentum. Overall, UHC expects approximately 13% adjusted operating earnings growth, ~40 basis points margin expansion, and membership contraction of 2.3 million to 2.8 million.

Optum

• OptumRx: Expect operating earnings growth from margin expansion of 20 basis points, driven by 800 new customer relationships and 95%+ customers electing full rebate pass through.
• OptumInsight: Expect earnings growth >4% with margin expansion ~90 basis points, with alignment of OptumFinancial Services with OptumInsight to enhance growth potential.
• OptumHealth: Expect operating earnings growth ~9% with margin expansion ~30 basis points, focusing on integrated value-based care, network optimization, and risk membership streamlining.

• Expect adjusted earnings per share of greater than $17.75 in 2026, a growth of at least 8.6%.
• Anticipate revenues of approximately $440 billion, net earnings of at least $17.10 per share, and adjusted net earnings of greater than $17.75 per share.
• Medical care ratio expected to be 88.8% ±50 basis points, operating cost ratio expected to be 12.8% ±50 basis points.

• Third year of Medicare funding reductions.
• Ongoing funding shortfalls within Medicaid state programs.
• Rising medical cost trends.
• Competitive market dynamics impacting membership.

Q: Josh Raskin asks about MA margins and their importance to other segments.

A: Stephen Hemsley and Tim Noel respond on margin recovery efforts in MA and the importance of MA to OptumHealth.

Q: Justin Lake asks about OptumHealth performance.

A: Stephen Hemsley and Krista Nelson discuss fourth quarter OptumHealth performance and confidence in more stable performance in 2026.

Q: Kevin Fischbeck asks about 2027 MA rate update.

A: Tim Noel and Krista Nelson talk about the impact of the rate update and confidence in margins.

Q: Lisa Gill asks about OptumRx Part D impact and new clients.

A: Bobby Hunter and Wayne DeVeydt discuss Part D seasonality and the reasons for new client wins.

Q: Scott Fidel asks about commercial business membership breakdown.

A: Dan Schumacher talks about commercial membership decline and margin progression.

Q: AJ Rice asks about 2027 growth expectations.

A: Stephen Hemsley discusses long-term growth potential.

Q: Erin Wright asks about Optum turnaround and value-based care.

A: Krista Nelson talks about Optum progress and the importance of value-based care.

Q: Jessica Tassan asks about independent reviews.

A: Stephen Hemsley and Krista Nelson discuss independent reviews and efforts to advance trust and transparency